About Us
Research Watch
•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छ•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Efficacy of measurement-based care (MBC) in routine child and youth behavioral therapy: A pragmatic randomized controlled trial.

Researchers

Christopher Hautmann, Felix Oswald, Jana Egemann, Nina Geldermann, Martin Hellmich, Kerstin Daniela Rosenberger, Kim de Jong, Maartje A M S van Sonsbeek, Danny Gehlen, Katrin Woitecki, Daniel Walter, Lydia Dachs, Anja Görtz-Dorten, Hildegard Goletz, Claudia Kinnen, Christiane Rademacher, Stephanie Schürmann, Tanja Wolff Metternich-Kaizman

Abstract

<b>Objective</b>: This pragmatic randomized trial evaluated a low-frequency measurement-based care (MBC) approach in children and youth. <b>Method:</b> In the modified intention-to-treat sample (mITT), 317 children (6-10) and youth (11-17) were randomized to behavioral therapy with or without MBC; 169 completed the trial per protocol (PP). Outcomes were assessed by masked raters, therapists, caregivers, and youth. <b>Results:</b> Average MBC participation ranged from 69% to 87% across informants, while therapists discussed the report at least once in only 29.3% of cases. In the mITT analysis, masked ratings of total symptoms (SFSS-I) showed no effect, <i>d</i>&#x2009;=&#x2009;0.00, 95% CI [-0.22, 0.22], while caregiver-rated externalizing symptoms (FBB-SCREEN) showed a small reduction, <i>d</i>&#x2009;=&#x2009;-0.17, [-0.33, -0.01]. In the PP analysis, masked ratings (SFSS-I) remained nonsignificant, <i>d</i>&#x2009;=&#x2009;-0.29, [-0.59, 0.01], but caregiver ratings showed significant reductions in externalizing (FBB-SCREEN), <i>d</i>&#x2009;=&#x2009;-0.29, [-0.53, -0.05], and internalizing symptoms (CBCL), <i>d</i>&#x2009;=&#x2009;-0.32, [-0.61, -0.03]. <b>Conclusions:</b> Low-frequency MBC may offer practical advantages for child and youth therapy, such as good participation, but its efficacy remained insufficient, likely reflecting implementation challenges. Differences between caregiver and masked outcomes may indicate a risk of overestimating treatment effects when assessments are unblinded.<b>Trial registration:</b> German Clinical Trials Register identifier: DRKS00016737.
Source: PubMed (PMID: 42888930)View Original on PubMed